nodes	percent_of_prediction	percent_of_DWPC	metapath
Amsacrine—ABCB1—Linagliptin—type 2 diabetes mellitus	0.095	0.176	CbGbCtD
Amsacrine—ABCB1—Sitagliptin—type 2 diabetes mellitus	0.0847	0.157	CbGbCtD
Amsacrine—ABCB1—Chlorpropamide—type 2 diabetes mellitus	0.0612	0.113	CbGbCtD
Amsacrine—CYP2D6—Pioglitazone—type 2 diabetes mellitus	0.0577	0.107	CbGbCtD
Amsacrine—CYP2D6—Rosiglitazone—type 2 diabetes mellitus	0.0532	0.0987	CbGbCtD
Amsacrine—CYP2D6—Nateglinide—type 2 diabetes mellitus	0.0437	0.081	CbGbCtD
Amsacrine—ABCB1—Bromocriptine—type 2 diabetes mellitus	0.0421	0.078	CbGbCtD
Amsacrine—CYP2D6—Irbesartan—type 2 diabetes mellitus	0.0419	0.0777	CbGbCtD
Amsacrine—ABCB1—Glyburide—type 2 diabetes mellitus	0.0313	0.0581	CbGbCtD
Amsacrine—ABCB1—Losartan—type 2 diabetes mellitus	0.0287	0.0531	CbGbCtD
Amsacrine—TOP2A—Methylergometrine—Bromocriptine—type 2 diabetes mellitus	0.00283	0.724	CbGdCrCtD
Amsacrine—TOP2A—Bortezomib—Nateglinide—type 2 diabetes mellitus	0.00108	0.276	CbGdCrCtD
Amsacrine—NCOA3—retina—type 2 diabetes mellitus	0.000518	0.157	CbGeAlD
Amsacrine—NCOA3—kidney—type 2 diabetes mellitus	0.000429	0.13	CbGeAlD
Amsacrine—NCOA3—cortex of kidney—type 2 diabetes mellitus	0.000418	0.126	CbGeAlD
Amsacrine—NCOA3—adipose tissue—type 2 diabetes mellitus	0.000387	0.117	CbGeAlD
Amsacrine—Dyspnoea—Glyburide—type 2 diabetes mellitus	0.000323	0.0011	CcSEcCtD
Amsacrine—Arrhythmia—Irbesartan—type 2 diabetes mellitus	0.000323	0.0011	CcSEcCtD
Amsacrine—Hypersensitivity—Sitagliptin—type 2 diabetes mellitus	0.000323	0.00109	CcSEcCtD
Amsacrine—Diarrhoea—Glipizide—type 2 diabetes mellitus	0.000322	0.00109	CcSEcCtD
Amsacrine—Renal failure—Ramipril—type 2 diabetes mellitus	0.00032	0.00108	CcSEcCtD
Amsacrine—Nausea—Rosiglitazone—type 2 diabetes mellitus	0.00032	0.00108	CcSEcCtD
Amsacrine—Thrombocytopenia—Gliclazide—type 2 diabetes mellitus	0.000319	0.00108	CcSEcCtD
Amsacrine—Tachycardia—Gliclazide—type 2 diabetes mellitus	0.000318	0.00108	CcSEcCtD
Amsacrine—Stomatitis—Ramipril—type 2 diabetes mellitus	0.000317	0.00107	CcSEcCtD
Amsacrine—Jaundice—Ramipril—type 2 diabetes mellitus	0.000317	0.00107	CcSEcCtD
Amsacrine—Skin disorder—Gliclazide—type 2 diabetes mellitus	0.000316	0.00107	CcSEcCtD
Amsacrine—Asthenia—Glimepiride—type 2 diabetes mellitus	0.000315	0.00107	CcSEcCtD
Amsacrine—Decreased appetite—Glyburide—type 2 diabetes mellitus	0.000315	0.00107	CcSEcCtD
Amsacrine—Urticaria—Bromocriptine—type 2 diabetes mellitus	0.000315	0.00107	CcSEcCtD
Amsacrine—Malnutrition—Irbesartan—type 2 diabetes mellitus	0.000315	0.00107	CcSEcCtD
Amsacrine—Vision blurred—Metformin—type 2 diabetes mellitus	0.000315	0.00107	CcSEcCtD
Amsacrine—Asthenia—Sitagliptin—type 2 diabetes mellitus	0.000314	0.00107	CcSEcCtD
Amsacrine—Convulsion—Orlistat—type 2 diabetes mellitus	0.000314	0.00106	CcSEcCtD
Amsacrine—Abdominal pain—Bromocriptine—type 2 diabetes mellitus	0.000314	0.00106	CcSEcCtD
Amsacrine—Body temperature increased—Bromocriptine—type 2 diabetes mellitus	0.000314	0.00106	CcSEcCtD
Amsacrine—Gastrointestinal disorder—Glyburide—type 2 diabetes mellitus	0.000313	0.00106	CcSEcCtD
Amsacrine—Dizziness—Glipizide—type 2 diabetes mellitus	0.000312	0.00106	CcSEcCtD
Amsacrine—Unspecified disorder of skin and subcutaneous tissue—Valsartan—type 2 diabetes mellitus	0.00031	0.00105	CcSEcCtD
Amsacrine—Angiopathy—Losartan—type 2 diabetes mellitus	0.000309	0.00105	CcSEcCtD
Amsacrine—Diarrhoea—Pioglitazone—type 2 diabetes mellitus	0.000309	0.00105	CcSEcCtD
Amsacrine—Hepatobiliary disease—Ramipril—type 2 diabetes mellitus	0.000308	0.00104	CcSEcCtD
Amsacrine—Unspecified disorder of skin and subcutaneous tissue—Orlistat—type 2 diabetes mellitus	0.000306	0.00104	CcSEcCtD
Amsacrine—Hypotension—Gliclazide—type 2 diabetes mellitus	0.000304	0.00103	CcSEcCtD
Amsacrine—Arrhythmia—Losartan—type 2 diabetes mellitus	0.000304	0.00103	CcSEcCtD
Amsacrine—Agranulocytosis—Ramipril—type 2 diabetes mellitus	0.000304	0.00103	CcSEcCtD
Amsacrine—Alopecia—Losartan—type 2 diabetes mellitus	0.000301	0.00102	CcSEcCtD
Amsacrine—Diarrhoea—Glimepiride—type 2 diabetes mellitus	0.000301	0.00102	CcSEcCtD
Amsacrine—Diarrhoea—Sitagliptin—type 2 diabetes mellitus	0.0003	0.00102	CcSEcCtD
Amsacrine—Vomiting—Glipizide—type 2 diabetes mellitus	0.0003	0.00102	CcSEcCtD
Amsacrine—Feeling abnormal—Glyburide—type 2 diabetes mellitus	0.000299	0.00101	CcSEcCtD
Amsacrine—Dizziness—Pioglitazone—type 2 diabetes mellitus	0.000298	0.00101	CcSEcCtD
Amsacrine—Infection—Valsartan—type 2 diabetes mellitus	0.000297	0.00101	CcSEcCtD
Amsacrine—Rash—Glipizide—type 2 diabetes mellitus	0.000297	0.00101	CcSEcCtD
Amsacrine—Vision blurred—Irbesartan—type 2 diabetes mellitus	0.000297	0.00101	CcSEcCtD
Amsacrine—Dermatitis—Glipizide—type 2 diabetes mellitus	0.000297	0.00101	CcSEcCtD
Amsacrine—Gastrointestinal pain—Glyburide—type 2 diabetes mellitus	0.000296	0.00101	CcSEcCtD
Amsacrine—Headache—Glipizide—type 2 diabetes mellitus	0.000295	0.001	CcSEcCtD
Amsacrine—Infection—Orlistat—type 2 diabetes mellitus	0.000294	0.000996	CcSEcCtD
Amsacrine—Thrombocytopenia—Valsartan—type 2 diabetes mellitus	0.000293	0.000993	CcSEcCtD
Amsacrine—Paraesthesia—Gliclazide—type 2 diabetes mellitus	0.000292	0.000991	CcSEcCtD
Amsacrine—Hepatitis—Ramipril—type 2 diabetes mellitus	0.000292	0.00099	CcSEcCtD
Amsacrine—Anaemia—Irbesartan—type 2 diabetes mellitus	0.000291	0.000987	CcSEcCtD
Amsacrine—Dizziness—Glimepiride—type 2 diabetes mellitus	0.000291	0.000986	CcSEcCtD
Amsacrine—Skin disorder—Valsartan—type 2 diabetes mellitus	0.000291	0.000985	CcSEcCtD
Amsacrine—Dyspnoea—Gliclazide—type 2 diabetes mellitus	0.00029	0.000984	CcSEcCtD
Amsacrine—Dizziness—Sitagliptin—type 2 diabetes mellitus	0.00029	0.000983	CcSEcCtD
Amsacrine—Urticaria—Glyburide—type 2 diabetes mellitus	0.000288	0.000977	CcSEcCtD
Amsacrine—Skin disorder—Orlistat—type 2 diabetes mellitus	0.000287	0.000973	CcSEcCtD
Amsacrine—Connective tissue disorder—Ramipril—type 2 diabetes mellitus	0.000287	0.000973	CcSEcCtD
Amsacrine—Abdominal pain—Glyburide—type 2 diabetes mellitus	0.000287	0.000972	CcSEcCtD
Amsacrine—Anorexia—Valsartan—type 2 diabetes mellitus	0.000285	0.000967	CcSEcCtD
Amsacrine—Asthenia—Bromocriptine—type 2 diabetes mellitus	0.000285	0.000965	CcSEcCtD
Amsacrine—Headache—Pioglitazone—type 2 diabetes mellitus	0.000283	0.000959	CcSEcCtD
Amsacrine—Unspecified disorder of skin and subcutaneous tissue—Metformin—type 2 diabetes mellitus	0.000282	0.000957	CcSEcCtD
Amsacrine—Leukopenia—Irbesartan—type 2 diabetes mellitus	0.000282	0.000956	CcSEcCtD
Amsacrine—Gastrointestinal disorder—Gliclazide—type 2 diabetes mellitus	0.000281	0.000953	CcSEcCtD
Amsacrine—Fatigue—Gliclazide—type 2 diabetes mellitus	0.000281	0.000952	CcSEcCtD
Amsacrine—Nausea—Glipizide—type 2 diabetes mellitus	0.00028	0.000949	CcSEcCtD
Amsacrine—Vomiting—Glimepiride—type 2 diabetes mellitus	0.00028	0.000948	CcSEcCtD
Amsacrine—Hypotension—Valsartan—type 2 diabetes mellitus	0.000279	0.000948	CcSEcCtD
Amsacrine—Vision blurred—Losartan—type 2 diabetes mellitus	0.000279	0.000947	CcSEcCtD
Amsacrine—Vomiting—Sitagliptin—type 2 diabetes mellitus	0.000279	0.000945	CcSEcCtD
Amsacrine—Pain—Gliclazide—type 2 diabetes mellitus	0.000278	0.000944	CcSEcCtD
Amsacrine—Rash—Glimepiride—type 2 diabetes mellitus	0.000277	0.00094	CcSEcCtD
Amsacrine—Dermatitis—Glimepiride—type 2 diabetes mellitus	0.000277	0.000939	CcSEcCtD
Amsacrine—Rash—Sitagliptin—type 2 diabetes mellitus	0.000276	0.000937	CcSEcCtD
Amsacrine—Dermatitis—Sitagliptin—type 2 diabetes mellitus	0.000276	0.000936	CcSEcCtD
Amsacrine—Headache—Glimepiride—type 2 diabetes mellitus	0.000275	0.000934	CcSEcCtD
Amsacrine—Headache—Sitagliptin—type 2 diabetes mellitus	0.000275	0.000931	CcSEcCtD
Amsacrine—Anaemia—Losartan—type 2 diabetes mellitus	0.000274	0.000929	CcSEcCtD
Amsacrine—Diarrhoea—Bromocriptine—type 2 diabetes mellitus	0.000271	0.00092	CcSEcCtD
Amsacrine—NCOA3—liver—type 2 diabetes mellitus	0.000271	0.082	CbGeAlD
Amsacrine—Infection—Metformin—type 2 diabetes mellitus	0.000271	0.000917	CcSEcCtD
Amsacrine—Paraesthesia—Valsartan—type 2 diabetes mellitus	0.000269	0.000911	CcSEcCtD
Amsacrine—Feeling abnormal—Gliclazide—type 2 diabetes mellitus	0.000268	0.00091	CcSEcCtD
Amsacrine—Hypersensitivity—Glyburide—type 2 diabetes mellitus	0.000267	0.000906	CcSEcCtD
Amsacrine—Thrombocytopenia—Metformin—type 2 diabetes mellitus	0.000267	0.000904	CcSEcCtD
Amsacrine—Dyspnoea—Valsartan—type 2 diabetes mellitus	0.000267	0.000904	CcSEcCtD
Amsacrine—Unspecified disorder of skin and subcutaneous tissue—Irbesartan—type 2 diabetes mellitus	0.000266	0.000903	CcSEcCtD
Amsacrine—Gastrointestinal pain—Gliclazide—type 2 diabetes mellitus	0.000266	0.000903	CcSEcCtD
Amsacrine—Paraesthesia—Orlistat—type 2 diabetes mellitus	0.000265	0.0009	CcSEcCtD
Amsacrine—Leukopenia—Losartan—type 2 diabetes mellitus	0.000265	0.0009	CcSEcCtD
Amsacrine—Skin disorder—Metformin—type 2 diabetes mellitus	0.000265	0.000897	CcSEcCtD
Amsacrine—Mediastinal disorder—Ramipril—type 2 diabetes mellitus	0.000263	0.000892	CcSEcCtD
Amsacrine—Dizziness—Bromocriptine—type 2 diabetes mellitus	0.000262	0.000889	CcSEcCtD
Amsacrine—Nausea—Glimepiride—type 2 diabetes mellitus	0.000261	0.000885	CcSEcCtD
Amsacrine—Arrhythmia—Ramipril—type 2 diabetes mellitus	0.000261	0.000884	CcSEcCtD
Amsacrine—Nausea—Sitagliptin—type 2 diabetes mellitus	0.00026	0.000883	CcSEcCtD
Amsacrine—Asthenia—Glyburide—type 2 diabetes mellitus	0.00026	0.000882	CcSEcCtD
Amsacrine—Decreased appetite—Valsartan—type 2 diabetes mellitus	0.00026	0.000882	CcSEcCtD
Amsacrine—Anorexia—Metformin—type 2 diabetes mellitus	0.00026	0.00088	CcSEcCtD
Amsacrine—Urticaria—Gliclazide—type 2 diabetes mellitus	0.000259	0.000877	CcSEcCtD
Amsacrine—Gastrointestinal disorder—Valsartan—type 2 diabetes mellitus	0.000258	0.000876	CcSEcCtD
Amsacrine—Alopecia—Ramipril—type 2 diabetes mellitus	0.000258	0.000875	CcSEcCtD
Amsacrine—Fatigue—Valsartan—type 2 diabetes mellitus	0.000258	0.000874	CcSEcCtD
Amsacrine—Abdominal pain—Gliclazide—type 2 diabetes mellitus	0.000257	0.000873	CcSEcCtD
Amsacrine—Body temperature increased—Gliclazide—type 2 diabetes mellitus	0.000257	0.000873	CcSEcCtD
Amsacrine—Decreased appetite—Orlistat—type 2 diabetes mellitus	0.000257	0.000871	CcSEcCtD
Amsacrine—Mental disorder—Ramipril—type 2 diabetes mellitus	0.000256	0.000867	CcSEcCtD
Amsacrine—Infection—Irbesartan—type 2 diabetes mellitus	0.000255	0.000866	CcSEcCtD
Amsacrine—Gastrointestinal disorder—Orlistat—type 2 diabetes mellitus	0.000255	0.000865	CcSEcCtD
Amsacrine—Fatigue—Orlistat—type 2 diabetes mellitus	0.000255	0.000864	CcSEcCtD
Amsacrine—Hypotension—Metformin—type 2 diabetes mellitus	0.000255	0.000863	CcSEcCtD
Amsacrine—Malnutrition—Ramipril—type 2 diabetes mellitus	0.000254	0.000862	CcSEcCtD
Amsacrine—Pain—Orlistat—type 2 diabetes mellitus	0.000253	0.000857	CcSEcCtD
Amsacrine—Vomiting—Bromocriptine—type 2 diabetes mellitus	0.000252	0.000855	CcSEcCtD
Amsacrine—Thrombocytopenia—Irbesartan—type 2 diabetes mellitus	0.000252	0.000853	CcSEcCtD
Amsacrine—Tachycardia—Irbesartan—type 2 diabetes mellitus	0.000251	0.000851	CcSEcCtD
Amsacrine—Rash—Bromocriptine—type 2 diabetes mellitus	0.00025	0.000848	CcSEcCtD
Amsacrine—Dermatitis—Bromocriptine—type 2 diabetes mellitus	0.00025	0.000847	CcSEcCtD
Amsacrine—Skin disorder—Irbesartan—type 2 diabetes mellitus	0.00025	0.000847	CcSEcCtD
Amsacrine—Headache—Bromocriptine—type 2 diabetes mellitus	0.000248	0.000842	CcSEcCtD
Amsacrine—Diarrhoea—Glyburide—type 2 diabetes mellitus	0.000248	0.000841	CcSEcCtD
Amsacrine—Anorexia—Irbesartan—type 2 diabetes mellitus	0.000245	0.000831	CcSEcCtD
Amsacrine—Gastrointestinal pain—Valsartan—type 2 diabetes mellitus	0.000245	0.000829	CcSEcCtD
Amsacrine—Paraesthesia—Metformin—type 2 diabetes mellitus	0.000245	0.000829	CcSEcCtD
Amsacrine—Confusional state—Losartan—type 2 diabetes mellitus	0.000244	0.000827	CcSEcCtD
Amsacrine—Feeling abnormal—Orlistat—type 2 diabetes mellitus	0.000244	0.000826	CcSEcCtD
Amsacrine—Dyspnoea—Metformin—type 2 diabetes mellitus	0.000243	0.000823	CcSEcCtD
Amsacrine—Gastrointestinal pain—Orlistat—type 2 diabetes mellitus	0.000242	0.000819	CcSEcCtD
Amsacrine—Infection—Losartan—type 2 diabetes mellitus	0.00024	0.000815	CcSEcCtD
Amsacrine—Hypotension—Irbesartan—type 2 diabetes mellitus	0.00024	0.000814	CcSEcCtD
Amsacrine—Hypersensitivity—Gliclazide—type 2 diabetes mellitus	0.00024	0.000813	CcSEcCtD
Amsacrine—Urticaria—Valsartan—type 2 diabetes mellitus	0.000238	0.000806	CcSEcCtD
Amsacrine—Thrombocytopenia—Losartan—type 2 diabetes mellitus	0.000237	0.000803	CcSEcCtD
Amsacrine—Decreased appetite—Metformin—type 2 diabetes mellitus	0.000237	0.000803	CcSEcCtD
Amsacrine—Abdominal pain—Valsartan—type 2 diabetes mellitus	0.000236	0.000802	CcSEcCtD
Amsacrine—Tachycardia—Losartan—type 2 diabetes mellitus	0.000236	0.0008	CcSEcCtD
Amsacrine—Nausea—Bromocriptine—type 2 diabetes mellitus	0.000236	0.000799	CcSEcCtD
Amsacrine—Gastrointestinal disorder—Metformin—type 2 diabetes mellitus	0.000235	0.000797	CcSEcCtD
Amsacrine—Fatigue—Metformin—type 2 diabetes mellitus	0.000235	0.000796	CcSEcCtD
Amsacrine—Urticaria—Orlistat—type 2 diabetes mellitus	0.000235	0.000796	CcSEcCtD
Amsacrine—Abdominal pain—Orlistat—type 2 diabetes mellitus	0.000234	0.000792	CcSEcCtD
Amsacrine—Body temperature increased—Orlistat—type 2 diabetes mellitus	0.000234	0.000792	CcSEcCtD
Amsacrine—Asthenia—Gliclazide—type 2 diabetes mellitus	0.000234	0.000792	CcSEcCtD
Amsacrine—Paraesthesia—Irbesartan—type 2 diabetes mellitus	0.000231	0.000783	CcSEcCtD
Amsacrine—Anorexia—Losartan—type 2 diabetes mellitus	0.000231	0.000782	CcSEcCtD
Amsacrine—Vomiting—Glyburide—type 2 diabetes mellitus	0.000231	0.000782	CcSEcCtD
Amsacrine—Dyspnoea—Irbesartan—type 2 diabetes mellitus	0.000229	0.000777	CcSEcCtD
Amsacrine—Rash—Glyburide—type 2 diabetes mellitus	0.000229	0.000775	CcSEcCtD
Amsacrine—Dermatitis—Glyburide—type 2 diabetes mellitus	0.000228	0.000774	CcSEcCtD
Amsacrine—Leukopenia—Ramipril—type 2 diabetes mellitus	0.000228	0.000771	CcSEcCtD
Amsacrine—Headache—Glyburide—type 2 diabetes mellitus	0.000227	0.00077	CcSEcCtD
Amsacrine—TOP2A—adipose tissue—type 2 diabetes mellitus	0.000227	0.0686	CbGeAlD
Amsacrine—Hypotension—Losartan—type 2 diabetes mellitus	0.000226	0.000766	CcSEcCtD
Amsacrine—Feeling abnormal—Metformin—type 2 diabetes mellitus	0.000224	0.000761	CcSEcCtD
Amsacrine—Decreased appetite—Irbesartan—type 2 diabetes mellitus	0.000223	0.000758	CcSEcCtD
Amsacrine—Diarrhoea—Gliclazide—type 2 diabetes mellitus	0.000223	0.000755	CcSEcCtD
Amsacrine—Gastrointestinal pain—Metformin—type 2 diabetes mellitus	0.000223	0.000755	CcSEcCtD
Amsacrine—Gastrointestinal disorder—Irbesartan—type 2 diabetes mellitus	0.000222	0.000752	CcSEcCtD
Amsacrine—Fatigue—Irbesartan—type 2 diabetes mellitus	0.000222	0.000751	CcSEcCtD
Amsacrine—Hypersensitivity—Valsartan—type 2 diabetes mellitus	0.00022	0.000747	CcSEcCtD
Amsacrine—Convulsion—Ramipril—type 2 diabetes mellitus	0.00022	0.000747	CcSEcCtD
Amsacrine—Pain—Irbesartan—type 2 diabetes mellitus	0.00022	0.000745	CcSEcCtD
Amsacrine—Hypersensitivity—Orlistat—type 2 diabetes mellitus	0.000218	0.000738	CcSEcCtD
Amsacrine—Paraesthesia—Losartan—type 2 diabetes mellitus	0.000217	0.000736	CcSEcCtD
Amsacrine—Urticaria—Metformin—type 2 diabetes mellitus	0.000216	0.000734	CcSEcCtD
Amsacrine—Dyspnoea—Losartan—type 2 diabetes mellitus	0.000216	0.000731	CcSEcCtD
Amsacrine—Nausea—Glyburide—type 2 diabetes mellitus	0.000215	0.00073	CcSEcCtD
Amsacrine—Abdominal pain—Metformin—type 2 diabetes mellitus	0.000215	0.00073	CcSEcCtD
Amsacrine—Dizziness—Gliclazide—type 2 diabetes mellitus	0.000215	0.00073	CcSEcCtD
Amsacrine—Unspecified disorder of skin and subcutaneous tissue—Ramipril—type 2 diabetes mellitus	0.000215	0.000729	CcSEcCtD
Amsacrine—Asthenia—Valsartan—type 2 diabetes mellitus	0.000215	0.000728	CcSEcCtD
Amsacrine—Asthenia—Orlistat—type 2 diabetes mellitus	0.000212	0.000719	CcSEcCtD
Amsacrine—Feeling abnormal—Irbesartan—type 2 diabetes mellitus	0.000212	0.000718	CcSEcCtD
Amsacrine—Decreased appetite—Losartan—type 2 diabetes mellitus	0.00021	0.000713	CcSEcCtD
Amsacrine—Gastrointestinal pain—Irbesartan—type 2 diabetes mellitus	0.00021	0.000713	CcSEcCtD
Amsacrine—Confusional state—Ramipril—type 2 diabetes mellitus	0.000209	0.000709	CcSEcCtD
Amsacrine—Fatigue—Losartan—type 2 diabetes mellitus	0.000209	0.000707	CcSEcCtD
Amsacrine—Vomiting—Gliclazide—type 2 diabetes mellitus	0.000207	0.000702	CcSEcCtD
Amsacrine—Pain—Losartan—type 2 diabetes mellitus	0.000207	0.000701	CcSEcCtD
Amsacrine—Rash—Gliclazide—type 2 diabetes mellitus	0.000205	0.000696	CcSEcCtD
Amsacrine—Dermatitis—Gliclazide—type 2 diabetes mellitus	0.000205	0.000695	CcSEcCtD
Amsacrine—Diarrhoea—Valsartan—type 2 diabetes mellitus	0.000205	0.000694	CcSEcCtD
Amsacrine—Urticaria—Irbesartan—type 2 diabetes mellitus	0.000204	0.000692	CcSEcCtD
Amsacrine—Headache—Gliclazide—type 2 diabetes mellitus	0.000204	0.000691	CcSEcCtD
Amsacrine—Abdominal pain—Irbesartan—type 2 diabetes mellitus	0.000203	0.000689	CcSEcCtD
Amsacrine—Body temperature increased—Irbesartan—type 2 diabetes mellitus	0.000203	0.000689	CcSEcCtD
Amsacrine—Thrombocytopenia—Ramipril—type 2 diabetes mellitus	0.000203	0.000689	CcSEcCtD
Amsacrine—Tachycardia—Ramipril—type 2 diabetes mellitus	0.000202	0.000686	CcSEcCtD
Amsacrine—Diarrhoea—Orlistat—type 2 diabetes mellitus	0.000202	0.000686	CcSEcCtD
Amsacrine—Skin disorder—Ramipril—type 2 diabetes mellitus	0.000201	0.000683	CcSEcCtD
Amsacrine—KCNH2—islet of Langerhans—type 2 diabetes mellitus	0.000199	0.0603	CbGeAlD
Amsacrine—Feeling abnormal—Losartan—type 2 diabetes mellitus	0.000199	0.000676	CcSEcCtD
Amsacrine—Gastrointestinal pain—Losartan—type 2 diabetes mellitus	0.000198	0.000671	CcSEcCtD
Amsacrine—Dizziness—Valsartan—type 2 diabetes mellitus	0.000198	0.000671	CcSEcCtD
Amsacrine—Anorexia—Ramipril—type 2 diabetes mellitus	0.000198	0.00067	CcSEcCtD
Amsacrine—Dizziness—Orlistat—type 2 diabetes mellitus	0.000195	0.000663	CcSEcCtD
Amsacrine—Asthenia—Metformin—type 2 diabetes mellitus	0.000195	0.000663	CcSEcCtD
Amsacrine—Hypotension—Ramipril—type 2 diabetes mellitus	0.000194	0.000657	CcSEcCtD
Amsacrine—Nausea—Gliclazide—type 2 diabetes mellitus	0.000193	0.000656	CcSEcCtD
Amsacrine—Urticaria—Losartan—type 2 diabetes mellitus	0.000192	0.000652	CcSEcCtD
Amsacrine—Body temperature increased—Losartan—type 2 diabetes mellitus	0.000191	0.000648	CcSEcCtD
Amsacrine—Abdominal pain—Losartan—type 2 diabetes mellitus	0.000191	0.000648	CcSEcCtD
Amsacrine—Vomiting—Valsartan—type 2 diabetes mellitus	0.00019	0.000645	CcSEcCtD
Amsacrine—Hypersensitivity—Irbesartan—type 2 diabetes mellitus	0.000189	0.000642	CcSEcCtD
Amsacrine—Rash—Valsartan—type 2 diabetes mellitus	0.000189	0.000639	CcSEcCtD
Amsacrine—Dermatitis—Valsartan—type 2 diabetes mellitus	0.000188	0.000639	CcSEcCtD
Amsacrine—Vomiting—Orlistat—type 2 diabetes mellitus	0.000188	0.000637	CcSEcCtD
Amsacrine—Headache—Valsartan—type 2 diabetes mellitus	0.000187	0.000635	CcSEcCtD
Amsacrine—Diarrhoea—Metformin—type 2 diabetes mellitus	0.000186	0.000632	CcSEcCtD
Amsacrine—Rash—Orlistat—type 2 diabetes mellitus	0.000186	0.000632	CcSEcCtD
Amsacrine—Paraesthesia—Ramipril—type 2 diabetes mellitus	0.000186	0.000632	CcSEcCtD
Amsacrine—Dermatitis—Orlistat—type 2 diabetes mellitus	0.000186	0.000631	CcSEcCtD
Amsacrine—Headache—Orlistat—type 2 diabetes mellitus	0.000185	0.000628	CcSEcCtD
Amsacrine—Dyspnoea—Ramipril—type 2 diabetes mellitus	0.000185	0.000627	CcSEcCtD
Amsacrine—Asthenia—Irbesartan—type 2 diabetes mellitus	0.000184	0.000625	CcSEcCtD
Amsacrine—Decreased appetite—Ramipril—type 2 diabetes mellitus	0.00018	0.000611	CcSEcCtD
Amsacrine—Dizziness—Metformin—type 2 diabetes mellitus	0.00018	0.000611	CcSEcCtD
Amsacrine—Gastrointestinal disorder—Ramipril—type 2 diabetes mellitus	0.000179	0.000607	CcSEcCtD
Amsacrine—Fatigue—Ramipril—type 2 diabetes mellitus	0.000179	0.000606	CcSEcCtD
Amsacrine—Hypersensitivity—Losartan—type 2 diabetes mellitus	0.000178	0.000604	CcSEcCtD
Amsacrine—Nausea—Valsartan—type 2 diabetes mellitus	0.000178	0.000602	CcSEcCtD
Amsacrine—Diarrhoea—Irbesartan—type 2 diabetes mellitus	0.000176	0.000596	CcSEcCtD
Amsacrine—Nausea—Orlistat—type 2 diabetes mellitus	0.000176	0.000595	CcSEcCtD
Amsacrine—Asthenia—Losartan—type 2 diabetes mellitus	0.000174	0.000588	CcSEcCtD
Amsacrine—Vomiting—Metformin—type 2 diabetes mellitus	0.000173	0.000587	CcSEcCtD
Amsacrine—Rash—Metformin—type 2 diabetes mellitus	0.000172	0.000582	CcSEcCtD
Amsacrine—Dermatitis—Metformin—type 2 diabetes mellitus	0.000172	0.000582	CcSEcCtD
Amsacrine—Feeling abnormal—Ramipril—type 2 diabetes mellitus	0.000171	0.00058	CcSEcCtD
Amsacrine—Headache—Metformin—type 2 diabetes mellitus	0.000171	0.000579	CcSEcCtD
Amsacrine—Dizziness—Irbesartan—type 2 diabetes mellitus	0.00017	0.000576	CcSEcCtD
Amsacrine—Gastrointestinal pain—Ramipril—type 2 diabetes mellitus	0.00017	0.000575	CcSEcCtD
Amsacrine—Diarrhoea—Losartan—type 2 diabetes mellitus	0.000166	0.000561	CcSEcCtD
Amsacrine—Urticaria—Ramipril—type 2 diabetes mellitus	0.000165	0.000559	CcSEcCtD
Amsacrine—Body temperature increased—Ramipril—type 2 diabetes mellitus	0.000164	0.000556	CcSEcCtD
Amsacrine—Abdominal pain—Ramipril—type 2 diabetes mellitus	0.000164	0.000556	CcSEcCtD
Amsacrine—Vomiting—Irbesartan—type 2 diabetes mellitus	0.000163	0.000554	CcSEcCtD
Amsacrine—Rash—Irbesartan—type 2 diabetes mellitus	0.000162	0.00055	CcSEcCtD
Amsacrine—Dermatitis—Irbesartan—type 2 diabetes mellitus	0.000162	0.000549	CcSEcCtD
Amsacrine—Nausea—Metformin—type 2 diabetes mellitus	0.000162	0.000549	CcSEcCtD
Amsacrine—Headache—Irbesartan—type 2 diabetes mellitus	0.000161	0.000546	CcSEcCtD
Amsacrine—Dizziness—Losartan—type 2 diabetes mellitus	0.00016	0.000542	CcSEcCtD
Amsacrine—Vomiting—Losartan—type 2 diabetes mellitus	0.000154	0.000521	CcSEcCtD
Amsacrine—Hypersensitivity—Ramipril—type 2 diabetes mellitus	0.000153	0.000518	CcSEcCtD
Amsacrine—Nausea—Irbesartan—type 2 diabetes mellitus	0.000153	0.000518	CcSEcCtD
Amsacrine—Rash—Losartan—type 2 diabetes mellitus	0.000153	0.000517	CcSEcCtD
Amsacrine—Dermatitis—Losartan—type 2 diabetes mellitus	0.000152	0.000517	CcSEcCtD
Amsacrine—Headache—Losartan—type 2 diabetes mellitus	0.000152	0.000514	CcSEcCtD
Amsacrine—Asthenia—Ramipril—type 2 diabetes mellitus	0.000149	0.000505	CcSEcCtD
Amsacrine—KCNH2—cardiovascular system—type 2 diabetes mellitus	0.000144	0.0436	CbGeAlD
Amsacrine—Nausea—Losartan—type 2 diabetes mellitus	0.000144	0.000487	CcSEcCtD
Amsacrine—Diarrhoea—Ramipril—type 2 diabetes mellitus	0.000142	0.000481	CcSEcCtD
Amsacrine—Dizziness—Ramipril—type 2 diabetes mellitus	0.000137	0.000465	CcSEcCtD
Amsacrine—Vomiting—Ramipril—type 2 diabetes mellitus	0.000132	0.000447	CcSEcCtD
Amsacrine—Rash—Ramipril—type 2 diabetes mellitus	0.000131	0.000443	CcSEcCtD
Amsacrine—Dermatitis—Ramipril—type 2 diabetes mellitus	0.000131	0.000443	CcSEcCtD
Amsacrine—Headache—Ramipril—type 2 diabetes mellitus	0.00013	0.000441	CcSEcCtD
Amsacrine—Nausea—Ramipril—type 2 diabetes mellitus	0.000123	0.000418	CcSEcCtD
Amsacrine—ABCB1—islet of Langerhans—type 2 diabetes mellitus	8.75e-05	0.0264	CbGeAlD
Amsacrine—CYP2D6—kidney—type 2 diabetes mellitus	8.6e-05	0.026	CbGeAlD
Amsacrine—ABCB1—retina—type 2 diabetes mellitus	7.48e-05	0.0226	CbGeAlD
Amsacrine—ABCB1—nephron tubule—type 2 diabetes mellitus	7.04e-05	0.0213	CbGeAlD
Amsacrine—CYP2D6—Metapathway biotransformation—CYP3A4—type 2 diabetes mellitus	6.99e-05	0.000442	CbGpPWpGaD
Amsacrine—NCOA3—Metabolism—LPL—type 2 diabetes mellitus	6.87e-05	0.000435	CbGpPWpGaD
Amsacrine—ABCB1—Transmembrane transport of small molecules—TRPC1—type 2 diabetes mellitus	6.78e-05	0.000429	CbGpPWpGaD
Amsacrine—ABCB1—Transmembrane transport of small molecules—G6PC—type 2 diabetes mellitus	6.78e-05	0.000429	CbGpPWpGaD
Amsacrine—NCOA3—Metabolism—ADCY5—type 2 diabetes mellitus	6.73e-05	0.000425	CbGpPWpGaD
Amsacrine—TOP2A—Integrated Pancreatic Cancer Pathway—TGFB1—type 2 diabetes mellitus	6.73e-05	0.000425	CbGpPWpGaD
Amsacrine—NCOA3—Metabolism—GPX1—type 2 diabetes mellitus	6.71e-05	0.000424	CbGpPWpGaD
Amsacrine—NCOA3—Developmental Biology—TNF—type 2 diabetes mellitus	6.7e-05	0.000424	CbGpPWpGaD
Amsacrine—TOP2A—Integrated Pancreatic Cancer Pathway—EGFR—type 2 diabetes mellitus	6.6e-05	0.000417	CbGpPWpGaD
Amsacrine—TOP2A—Cell Cycle—PPP2CA—type 2 diabetes mellitus	6.58e-05	0.000416	CbGpPWpGaD
Amsacrine—NCOA3—Metabolism—CD36—type 2 diabetes mellitus	6.53e-05	0.000413	CbGpPWpGaD
Amsacrine—NCOA3—Metabolism—PPP2CA—type 2 diabetes mellitus	6.45e-05	0.000408	CbGpPWpGaD
Amsacrine—ABCB1—cardiovascular system—type 2 diabetes mellitus	6.32e-05	0.0191	CbGeAlD
Amsacrine—TOP2A—Integrated Pancreatic Cancer Pathway—TNF—type 2 diabetes mellitus	6.28e-05	0.000397	CbGpPWpGaD
Amsacrine—ABCB1—Integrated Pancreatic Cancer Pathway—AR—type 2 diabetes mellitus	6.22e-05	0.000393	CbGpPWpGaD
Amsacrine—ABCB1—Transmembrane transport of small molecules—PLN—type 2 diabetes mellitus	6.2e-05	0.000392	CbGpPWpGaD
Amsacrine—TOP2A—Cell Cycle, Mitotic—PRKCB—type 2 diabetes mellitus	6.2e-05	0.000392	CbGpPWpGaD
Amsacrine—NCOA3—Metabolism—MTHFR—type 2 diabetes mellitus	6.19e-05	0.000391	CbGpPWpGaD
Amsacrine—ABCB1—kidney—type 2 diabetes mellitus	6.19e-05	0.0187	CbGeAlD
Amsacrine—ABCB1—pancreas—type 2 diabetes mellitus	6.15e-05	0.0186	CbGeAlD
Amsacrine—NCOA3—Metabolism—PPARA—type 2 diabetes mellitus	6.07e-05	0.000384	CbGpPWpGaD
Amsacrine—ABCB1—cortex of kidney—type 2 diabetes mellitus	6.03e-05	0.0182	CbGeAlD
Amsacrine—NCOA3—Metabolism—AGT—type 2 diabetes mellitus	5.88e-05	0.000372	CbGpPWpGaD
Amsacrine—NCOA3—Metabolism—CALM1—type 2 diabetes mellitus	5.78e-05	0.000366	CbGpPWpGaD
Amsacrine—ABCB1—Allograft Rejection—CASP3—type 2 diabetes mellitus	5.77e-05	0.000364	CbGpPWpGaD
Amsacrine—NCOA3—Metabolism—APOE—type 2 diabetes mellitus	5.76e-05	0.000364	CbGpPWpGaD
Amsacrine—KCNH2—SIDS Susceptibility Pathways—IL6—type 2 diabetes mellitus	5.76e-05	0.000364	CbGpPWpGaD
Amsacrine—ABCB1—Integrated Pancreatic Cancer Pathway—CDKN2B—type 2 diabetes mellitus	5.73e-05	0.000362	CbGpPWpGaD
Amsacrine—NCOA3—Metabolism—APOA1—type 2 diabetes mellitus	5.7e-05	0.00036	CbGpPWpGaD
Amsacrine—ABCB1—Integrated Pancreatic Cancer Pathway—SIRT1—type 2 diabetes mellitus	5.67e-05	0.000358	CbGpPWpGaD
Amsacrine—ABCB1—HIF-1-alpha transcription factor network—VEGFA—type 2 diabetes mellitus	5.65e-05	0.000357	CbGpPWpGaD
Amsacrine—ABCB1—adipose tissue—type 2 diabetes mellitus	5.58e-05	0.0169	CbGeAlD
Amsacrine—CYP2D6—Biological oxidations—GSTM1—type 2 diabetes mellitus	5.57e-05	0.000352	CbGpPWpGaD
Amsacrine—TOP2A—Cell Cycle—PRKCB—type 2 diabetes mellitus	5.55e-05	0.000351	CbGpPWpGaD
Amsacrine—ABCB1—Transmembrane transport of small molecules—ABCC8—type 2 diabetes mellitus	5.53e-05	0.00035	CbGpPWpGaD
Amsacrine—ABCB1—Transmembrane transport of small molecules—SLC30A8—type 2 diabetes mellitus	5.53e-05	0.00035	CbGpPWpGaD
Amsacrine—CYP2D6—Metapathway biotransformation—GSTM1—type 2 diabetes mellitus	5.49e-05	0.000347	CbGpPWpGaD
Amsacrine—CYP2D6—liver—type 2 diabetes mellitus	5.44e-05	0.0164	CbGeAlD
Amsacrine—NCOA3—Developmental Biology—IL6—type 2 diabetes mellitus	5.41e-05	0.000342	CbGpPWpGaD
Amsacrine—ABCB1—Transmembrane transport of small molecules—SLC5A2—type 2 diabetes mellitus	5.32e-05	0.000336	CbGpPWpGaD
Amsacrine—ABCB1—Transmembrane transport of small molecules—COX2—type 2 diabetes mellitus	5.32e-05	0.000336	CbGpPWpGaD
Amsacrine—ABCB1—Transmembrane transport of small molecules—NCOA6—type 2 diabetes mellitus	5.23e-05	0.000331	CbGpPWpGaD
Amsacrine—NCOA3—Metabolism—PPARG—type 2 diabetes mellitus	5.02e-05	0.000317	CbGpPWpGaD
Amsacrine—NCOA3—Developmental Biology—AKT1—type 2 diabetes mellitus	4.99e-05	0.000315	CbGpPWpGaD
Amsacrine—NCOA3—Metabolism—INS—type 2 diabetes mellitus	4.92e-05	0.000311	CbGpPWpGaD
Amsacrine—ABCB1—Allograft Rejection—VEGFA—type 2 diabetes mellitus	4.89e-05	0.000309	CbGpPWpGaD
Amsacrine—ABCB1—Integrated Pancreatic Cancer Pathway—FAS—type 2 diabetes mellitus	4.87e-05	0.000308	CbGpPWpGaD
Amsacrine—TOP2A—Circadian rythm related genes—IL6—type 2 diabetes mellitus	4.87e-05	0.000308	CbGpPWpGaD
Amsacrine—ABCB1—Transmembrane transport of small molecules—ATP2A3—type 2 diabetes mellitus	4.83e-05	0.000305	CbGpPWpGaD
Amsacrine—TOP2A—Cell Cycle, Mitotic—CDKN2A—type 2 diabetes mellitus	4.82e-05	0.000305	CbGpPWpGaD
Amsacrine—TOP2A—Integrated Pancreatic Cancer Pathway—AKT1—type 2 diabetes mellitus	4.68e-05	0.000296	CbGpPWpGaD
Amsacrine—ABCB1—Transmembrane transport of small molecules—HK1—type 2 diabetes mellitus	4.53e-05	0.000286	CbGpPWpGaD
Amsacrine—NCOA3—Metabolism—ALB—type 2 diabetes mellitus	4.51e-05	0.000285	CbGpPWpGaD
Amsacrine—ABCB1—Metabolism—BHMT—type 2 diabetes mellitus	4.51e-05	0.000285	CbGpPWpGaD
Amsacrine—ABCB1—Allograft Rejection—TGFB1—type 2 diabetes mellitus	4.49e-05	0.000284	CbGpPWpGaD
Amsacrine—ABCB1—Transmembrane transport of small molecules—GCKR—type 2 diabetes mellitus	4.37e-05	0.000276	CbGpPWpGaD
Amsacrine—NCOA3—Metabolism—NOS3—type 2 diabetes mellitus	4.32e-05	0.000273	CbGpPWpGaD
Amsacrine—NCOA3—Metabolism—PIK3R1—type 2 diabetes mellitus	4.32e-05	0.000273	CbGpPWpGaD
Amsacrine—TOP2A—Cell Cycle—CDKN2A—type 2 diabetes mellitus	4.31e-05	0.000272	CbGpPWpGaD
Amsacrine—CYP2D6—Metabolism—BHMT—type 2 diabetes mellitus	4.25e-05	0.000269	CbGpPWpGaD
Amsacrine—ABCB1—Allograft Rejection—TNF—type 2 diabetes mellitus	4.19e-05	0.000265	CbGpPWpGaD
Amsacrine—ABCB1—Transmembrane transport of small molecules—ABCC2—type 2 diabetes mellitus	4.19e-05	0.000265	CbGpPWpGaD
Amsacrine—NCOA3—Metabolism—PTGS2—type 2 diabetes mellitus	3.95e-05	0.00025	CbGpPWpGaD
Amsacrine—ABCB1—Metabolism—AANAT—type 2 diabetes mellitus	3.94e-05	0.000249	CbGpPWpGaD
Amsacrine—ABCB1—Metabolism—PTGDS—type 2 diabetes mellitus	3.94e-05	0.000249	CbGpPWpGaD
Amsacrine—ABCB1—liver—type 2 diabetes mellitus	3.91e-05	0.0118	CbGeAlD
Amsacrine—ABCB1—Integrated Pancreatic Cancer Pathway—CASP8—type 2 diabetes mellitus	3.76e-05	0.000238	CbGpPWpGaD
Amsacrine—ABCB1—Metabolism—CDO1—type 2 diabetes mellitus	3.74e-05	0.000236	CbGpPWpGaD
Amsacrine—ABCB1—Metabolism—GPD2—type 2 diabetes mellitus	3.74e-05	0.000236	CbGpPWpGaD
Amsacrine—CYP2D6—Metabolism—AANAT—type 2 diabetes mellitus	3.71e-05	0.000235	CbGpPWpGaD
Amsacrine—CYP2D6—Metabolism—PTGDS—type 2 diabetes mellitus	3.71e-05	0.000235	CbGpPWpGaD
Amsacrine—ABCB1—Integrated Pancreatic Cancer Pathway—IGF1—type 2 diabetes mellitus	3.7e-05	0.000234	CbGpPWpGaD
Amsacrine—ABCB1—Transmembrane transport of small molecules—SLC2A2—type 2 diabetes mellitus	3.64e-05	0.00023	CbGpPWpGaD
Amsacrine—ABCB1—HIF-1-alpha transcription factor network—AKT1—type 2 diabetes mellitus	3.6e-05	0.000228	CbGpPWpGaD
Amsacrine—ABCB1—Metabolism—AK1—type 2 diabetes mellitus	3.56e-05	0.000225	CbGpPWpGaD
Amsacrine—CYP2D6—Metabolism—CDO1—type 2 diabetes mellitus	3.52e-05	0.000223	CbGpPWpGaD
Amsacrine—CYP2D6—Metabolism—GPD2—type 2 diabetes mellitus	3.52e-05	0.000223	CbGpPWpGaD
Amsacrine—ABCB1—Transmembrane transport of small molecules—ATP2A2—type 2 diabetes mellitus	3.47e-05	0.000219	CbGpPWpGaD
Amsacrine—ABCB1—Transmembrane transport of small molecules—GCK—type 2 diabetes mellitus	3.47e-05	0.000219	CbGpPWpGaD
Amsacrine—ABCB1—Transmembrane transport of small molecules—SLC9A1—type 2 diabetes mellitus	3.39e-05	0.000214	CbGpPWpGaD
Amsacrine—ABCB1—Transmembrane transport of small molecules—TRPC6—type 2 diabetes mellitus	3.37e-05	0.000213	CbGpPWpGaD
Amsacrine—CYP2D6—Metabolism—AK1—type 2 diabetes mellitus	3.36e-05	0.000212	CbGpPWpGaD
Amsacrine—ABCB1—Transmembrane transport of small molecules—CETP—type 2 diabetes mellitus	3.35e-05	0.000212	CbGpPWpGaD
Amsacrine—ABCB1—Metabolism—SLC5A4—type 2 diabetes mellitus	3.29e-05	0.000208	CbGpPWpGaD
Amsacrine—ABCB1—Metabolism—MAT1A—type 2 diabetes mellitus	3.29e-05	0.000208	CbGpPWpGaD
Amsacrine—ABCB1—Integrated Pancreatic Cancer Pathway—BCL2—type 2 diabetes mellitus	3.23e-05	0.000204	CbGpPWpGaD
Amsacrine—ABCB1—Metabolism—ENPP1—type 2 diabetes mellitus	3.18e-05	0.000201	CbGpPWpGaD
Amsacrine—ABCB1—Metabolism—ND1—type 2 diabetes mellitus	3.18e-05	0.000201	CbGpPWpGaD
Amsacrine—ABCB1—Metabolism—PPP1R3C—type 2 diabetes mellitus	3.18e-05	0.000201	CbGpPWpGaD
Amsacrine—ABCB1—Metabolism—G6PC—type 2 diabetes mellitus	3.18e-05	0.000201	CbGpPWpGaD
Amsacrine—ABCB1—Metabolism—HBA2—type 2 diabetes mellitus	3.18e-05	0.000201	CbGpPWpGaD
Amsacrine—CYP2D6—Metabolism—SLC5A4—type 2 diabetes mellitus	3.1e-05	0.000196	CbGpPWpGaD
Amsacrine—CYP2D6—Metabolism—MAT1A—type 2 diabetes mellitus	3.1e-05	0.000196	CbGpPWpGaD
Amsacrine—ABCB1—Metabolism—GCGR—type 2 diabetes mellitus	3.08e-05	0.000194	CbGpPWpGaD
Amsacrine—ABCB1—Integrated Pancreatic Cancer Pathway—PTGS2—type 2 diabetes mellitus	3.06e-05	0.000194	CbGpPWpGaD
Amsacrine—CYP2D6—Metabolism—ND1—type 2 diabetes mellitus	2.99e-05	0.000189	CbGpPWpGaD
Amsacrine—CYP2D6—Metabolism—PPP1R3C—type 2 diabetes mellitus	2.99e-05	0.000189	CbGpPWpGaD
Amsacrine—CYP2D6—Metabolism—ENPP1—type 2 diabetes mellitus	2.99e-05	0.000189	CbGpPWpGaD
Amsacrine—CYP2D6—Metabolism—G6PC—type 2 diabetes mellitus	2.99e-05	0.000189	CbGpPWpGaD
Amsacrine—CYP2D6—Metabolism—HBA2—type 2 diabetes mellitus	2.99e-05	0.000189	CbGpPWpGaD
Amsacrine—ABCB1—Transmembrane transport of small molecules—PLAT—type 2 diabetes mellitus	2.95e-05	0.000187	CbGpPWpGaD
Amsacrine—ABCB1—Metabolism—OXCT1—type 2 diabetes mellitus	2.91e-05	0.000184	CbGpPWpGaD
Amsacrine—ABCB1—Metabolism—CYTB—type 2 diabetes mellitus	2.91e-05	0.000184	CbGpPWpGaD
Amsacrine—CYP2D6—Metabolism—GCGR—type 2 diabetes mellitus	2.9e-05	0.000183	CbGpPWpGaD
Amsacrine—ABCB1—Integrated Pancreatic Cancer Pathway—CASP3—type 2 diabetes mellitus	2.85e-05	0.00018	CbGpPWpGaD
Amsacrine—ABCB1—Metabolism—SRD5A1—type 2 diabetes mellitus	2.83e-05	0.000179	CbGpPWpGaD
Amsacrine—ABCB1—Transmembrane transport of small molecules—SLC2A1—type 2 diabetes mellitus	2.82e-05	0.000178	CbGpPWpGaD
Amsacrine—CYP2D6—Metabolism—OXCT1—type 2 diabetes mellitus	2.74e-05	0.000173	CbGpPWpGaD
Amsacrine—CYP2D6—Metabolism—CYTB—type 2 diabetes mellitus	2.74e-05	0.000173	CbGpPWpGaD
Amsacrine—ABCB1—Metabolism—ACACA—type 2 diabetes mellitus	2.7e-05	0.000171	CbGpPWpGaD
Amsacrine—ABCB1—Metabolism—HSD17B3—type 2 diabetes mellitus	2.7e-05	0.000171	CbGpPWpGaD
Amsacrine—ABCB1—Metabolism—STAR—type 2 diabetes mellitus	2.7e-05	0.000171	CbGpPWpGaD
Amsacrine—ABCB1—Transmembrane transport of small molecules—SLC2A4—type 2 diabetes mellitus	2.7e-05	0.000171	CbGpPWpGaD
Amsacrine—CYP2D6—Metabolism—SRD5A1—type 2 diabetes mellitus	2.67e-05	0.000169	CbGpPWpGaD
Amsacrine—ABCB1—Integrated Pancreatic Cancer Pathway—NFKB1—type 2 diabetes mellitus	2.66e-05	0.000168	CbGpPWpGaD
Amsacrine—ABCB1—Metabolism—CBS—type 2 diabetes mellitus	2.59e-05	0.000164	CbGpPWpGaD
Amsacrine—ABCB1—Metabolism—ABCC8—type 2 diabetes mellitus	2.59e-05	0.000164	CbGpPWpGaD
Amsacrine—CYP2D6—Metabolism—HSD17B3—type 2 diabetes mellitus	2.55e-05	0.000161	CbGpPWpGaD
Amsacrine—CYP2D6—Metabolism—STAR—type 2 diabetes mellitus	2.55e-05	0.000161	CbGpPWpGaD
Amsacrine—CYP2D6—Metabolism—ACACA—type 2 diabetes mellitus	2.55e-05	0.000161	CbGpPWpGaD
Amsacrine—ABCB1—Metabolism—COX2—type 2 diabetes mellitus	2.49e-05	0.000158	CbGpPWpGaD
Amsacrine—ABCB1—Metabolism—SLC5A2—type 2 diabetes mellitus	2.49e-05	0.000158	CbGpPWpGaD
Amsacrine—ABCB1—Integrated Pancreatic Cancer Pathway—SRC—type 2 diabetes mellitus	2.48e-05	0.000157	CbGpPWpGaD
Amsacrine—ABCB1—Metabolism—NCOA6—type 2 diabetes mellitus	2.45e-05	0.000155	CbGpPWpGaD
Amsacrine—CYP2D6—Metabolism—ABCC8—type 2 diabetes mellitus	2.44e-05	0.000154	CbGpPWpGaD
Amsacrine—CYP2D6—Metabolism—CBS—type 2 diabetes mellitus	2.44e-05	0.000154	CbGpPWpGaD
Amsacrine—ABCB1—Integrated Pancreatic Cancer Pathway—VEGFA—type 2 diabetes mellitus	2.41e-05	0.000153	CbGpPWpGaD
Amsacrine—ABCB1—Metabolism—HSD11B1—type 2 diabetes mellitus	2.41e-05	0.000152	CbGpPWpGaD
Amsacrine—ABCB1—Metabolism—UCP3—type 2 diabetes mellitus	2.41e-05	0.000152	CbGpPWpGaD
Amsacrine—ABCB1—Metabolism—UCP2—type 2 diabetes mellitus	2.41e-05	0.000152	CbGpPWpGaD
Amsacrine—CYP2D6—Metabolism—COX2—type 2 diabetes mellitus	2.35e-05	0.000148	CbGpPWpGaD
Amsacrine—CYP2D6—Metabolism—SLC5A2—type 2 diabetes mellitus	2.35e-05	0.000148	CbGpPWpGaD
Amsacrine—ABCB1—Transmembrane transport of small molecules—GNB3—type 2 diabetes mellitus	2.33e-05	0.000147	CbGpPWpGaD
Amsacrine—ABCB1—Transmembrane transport of small molecules—HMOX1—type 2 diabetes mellitus	2.32e-05	0.000146	CbGpPWpGaD
Amsacrine—CYP2D6—Metabolism—NCOA6—type 2 diabetes mellitus	2.31e-05	0.000146	CbGpPWpGaD
Amsacrine—ABCB1—Transmembrane transport of small molecules—AVP—type 2 diabetes mellitus	2.3e-05	0.000145	CbGpPWpGaD
Amsacrine—CYP2D6—Metabolism—UCP2—type 2 diabetes mellitus	2.27e-05	0.000143	CbGpPWpGaD
Amsacrine—CYP2D6—Metabolism—HSD11B1—type 2 diabetes mellitus	2.27e-05	0.000143	CbGpPWpGaD
Amsacrine—CYP2D6—Metabolism—UCP3—type 2 diabetes mellitus	2.27e-05	0.000143	CbGpPWpGaD
Amsacrine—ABCB1—Metabolism—PCK1—type 2 diabetes mellitus	2.26e-05	0.000143	CbGpPWpGaD
Amsacrine—ABCB1—Transmembrane transport of small molecules—APOB—type 2 diabetes mellitus	2.22e-05	0.00014	CbGpPWpGaD
Amsacrine—ABCB1—Integrated Pancreatic Cancer Pathway—TGFB1—type 2 diabetes mellitus	2.22e-05	0.00014	CbGpPWpGaD
Amsacrine—ABCB1—Integrated Pancreatic Cancer Pathway—EGFR—type 2 diabetes mellitus	2.17e-05	0.000137	CbGpPWpGaD
Amsacrine—CYP2D6—Metabolism—PCK1—type 2 diabetes mellitus	2.13e-05	0.000135	CbGpPWpGaD
Amsacrine—ABCB1—Metabolism—HK1—type 2 diabetes mellitus	2.12e-05	0.000134	CbGpPWpGaD
Amsacrine—ABCB1—Transmembrane transport of small molecules—ADCY5—type 2 diabetes mellitus	2.07e-05	0.000131	CbGpPWpGaD
Amsacrine—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—type 2 diabetes mellitus	2.07e-05	0.000131	CbGpPWpGaD
Amsacrine—ABCB1—Metabolism—HSD3B2—type 2 diabetes mellitus	2.05e-05	0.000129	CbGpPWpGaD
Amsacrine—ABCB1—Metabolism—GCKR—type 2 diabetes mellitus	2.05e-05	0.000129	CbGpPWpGaD
Amsacrine—ABCB1—Metabolism—LPA—type 2 diabetes mellitus	2.05e-05	0.000129	CbGpPWpGaD
Amsacrine—ABCB1—Metabolism—KCNJ11—type 2 diabetes mellitus	2.05e-05	0.000129	CbGpPWpGaD
Amsacrine—CYP2D6—Metabolism—HK1—type 2 diabetes mellitus	2e-05	0.000126	CbGpPWpGaD
Amsacrine—NCOA3—Metabolism—AKT1—type 2 diabetes mellitus	1.98e-05	0.000125	CbGpPWpGaD
Amsacrine—ABCB1—Metabolism—ALDOB—type 2 diabetes mellitus	1.96e-05	0.000124	CbGpPWpGaD
Amsacrine—CYP2D6—Metabolism—KCNJ11—type 2 diabetes mellitus	1.93e-05	0.000122	CbGpPWpGaD
Amsacrine—CYP2D6—Metabolism—HSD3B2—type 2 diabetes mellitus	1.93e-05	0.000122	CbGpPWpGaD
Amsacrine—CYP2D6—Metabolism—LPA—type 2 diabetes mellitus	1.93e-05	0.000122	CbGpPWpGaD
Amsacrine—CYP2D6—Metabolism—GCKR—type 2 diabetes mellitus	1.93e-05	0.000122	CbGpPWpGaD
Amsacrine—ABCB1—Transmembrane transport of small molecules—PPARA—type 2 diabetes mellitus	1.87e-05	0.000118	CbGpPWpGaD
Amsacrine—CYP2D6—Metabolism—ALDOB—type 2 diabetes mellitus	1.85e-05	0.000117	CbGpPWpGaD
Amsacrine—ABCB1—Metabolism—GLP1R—type 2 diabetes mellitus	1.82e-05	0.000115	CbGpPWpGaD
Amsacrine—ABCB1—Transmembrane transport of small molecules—APOA1—type 2 diabetes mellitus	1.76e-05	0.000111	CbGpPWpGaD
Amsacrine—CYP2D6—Metabolism—GLP1R—type 2 diabetes mellitus	1.72e-05	0.000109	CbGpPWpGaD
Amsacrine—ABCB1—Metabolism—SLC2A2—type 2 diabetes mellitus	1.7e-05	0.000108	CbGpPWpGaD
Amsacrine—ABCB1—Metabolism—MTR—type 2 diabetes mellitus	1.67e-05	0.000105	CbGpPWpGaD
Amsacrine—ABCB1—Metabolism—CPT1A—type 2 diabetes mellitus	1.67e-05	0.000105	CbGpPWpGaD
Amsacrine—ABCB1—Metabolism—NAMPT—type 2 diabetes mellitus	1.64e-05	0.000103	CbGpPWpGaD
Amsacrine—ABCB1—Metabolism—HBA1—type 2 diabetes mellitus	1.63e-05	0.000103	CbGpPWpGaD
Amsacrine—ABCB1—Metabolism—LIPC—type 2 diabetes mellitus	1.63e-05	0.000103	CbGpPWpGaD
Amsacrine—ABCB1—Metabolism—GCK—type 2 diabetes mellitus	1.63e-05	0.000103	CbGpPWpGaD
Amsacrine—ABCB1—Metabolism—CYP11A1—type 2 diabetes mellitus	1.62e-05	0.000102	CbGpPWpGaD
Amsacrine—CYP2D6—Metabolism—SLC2A2—type 2 diabetes mellitus	1.61e-05	0.000101	CbGpPWpGaD
Amsacrine—ABCB1—Metabolism—SLC9A1—type 2 diabetes mellitus	1.59e-05	0.0001	CbGpPWpGaD
Amsacrine—CYP2D6—Metabolism—CPT1A—type 2 diabetes mellitus	1.57e-05	9.94e-05	CbGpPWpGaD
Amsacrine—CYP2D6—Metabolism—MTR—type 2 diabetes mellitus	1.57e-05	9.94e-05	CbGpPWpGaD
Amsacrine—ABCB1—Metabolism—CETP—type 2 diabetes mellitus	1.57e-05	9.92e-05	CbGpPWpGaD
Amsacrine—CYP2D6—Metabolism—NAMPT—type 2 diabetes mellitus	1.54e-05	9.75e-05	CbGpPWpGaD
Amsacrine—ABCB1—Integrated Pancreatic Cancer Pathway—AKT1—type 2 diabetes mellitus	1.54e-05	9.74e-05	CbGpPWpGaD
Amsacrine—CYP2D6—Metabolism—GCK—type 2 diabetes mellitus	1.53e-05	9.69e-05	CbGpPWpGaD
Amsacrine—CYP2D6—Metabolism—HBA1—type 2 diabetes mellitus	1.53e-05	9.69e-05	CbGpPWpGaD
Amsacrine—CYP2D6—Metabolism—LIPC—type 2 diabetes mellitus	1.53e-05	9.69e-05	CbGpPWpGaD
Amsacrine—CYP2D6—Metabolism—CYP11A1—type 2 diabetes mellitus	1.52e-05	9.63e-05	CbGpPWpGaD
Amsacrine—CYP2D6—Metabolism—SLC9A1—type 2 diabetes mellitus	1.5e-05	9.45e-05	CbGpPWpGaD
Amsacrine—CYP2D6—Metabolism—CETP—type 2 diabetes mellitus	1.48e-05	9.35e-05	CbGpPWpGaD
Amsacrine—ABCB1—Metabolism—SREBF1—type 2 diabetes mellitus	1.46e-05	9.22e-05	CbGpPWpGaD
Amsacrine—ABCB1—Metabolism—PSMD6—type 2 diabetes mellitus	1.46e-05	9.22e-05	CbGpPWpGaD
Amsacrine—ABCB1—Metabolism—SNAP25—type 2 diabetes mellitus	1.46e-05	9.22e-05	CbGpPWpGaD
Amsacrine—ABCB1—Metabolism—CTGF—type 2 diabetes mellitus	1.43e-05	9.05e-05	CbGpPWpGaD
Amsacrine—ABCB1—Metabolism—HMGCR—type 2 diabetes mellitus	1.42e-05	8.97e-05	CbGpPWpGaD
Amsacrine—ABCB1—Transmembrane transport of small molecules—ALB—type 2 diabetes mellitus	1.39e-05	8.79e-05	CbGpPWpGaD
Amsacrine—ABCB1—Metabolism—ADRA2A—type 2 diabetes mellitus	1.39e-05	8.78e-05	CbGpPWpGaD
Amsacrine—CYP2D6—Metabolism—SREBF1—type 2 diabetes mellitus	1.37e-05	8.69e-05	CbGpPWpGaD
Amsacrine—CYP2D6—Metabolism—SNAP25—type 2 diabetes mellitus	1.37e-05	8.69e-05	CbGpPWpGaD
Amsacrine—CYP2D6—Metabolism—PSMD6—type 2 diabetes mellitus	1.37e-05	8.69e-05	CbGpPWpGaD
Amsacrine—CYP2D6—Metabolism—CTGF—type 2 diabetes mellitus	1.35e-05	8.53e-05	CbGpPWpGaD
Amsacrine—CYP2D6—Metabolism—HMGCR—type 2 diabetes mellitus	1.34e-05	8.45e-05	CbGpPWpGaD
Amsacrine—ABCB1—Metabolism—CYP2E1—type 2 diabetes mellitus	1.33e-05	8.43e-05	CbGpPWpGaD
Amsacrine—ABCB1—Metabolism—CYP1A2—type 2 diabetes mellitus	1.32e-05	8.34e-05	CbGpPWpGaD
Amsacrine—ABCB1—Metabolism—SLC2A1—type 2 diabetes mellitus	1.32e-05	8.34e-05	CbGpPWpGaD
Amsacrine—CYP2D6—Metabolism—ADRA2A—type 2 diabetes mellitus	1.31e-05	8.27e-05	CbGpPWpGaD
Amsacrine—ABCB1—Metabolism—CYP3A4—type 2 diabetes mellitus	1.29e-05	8.13e-05	CbGpPWpGaD
Amsacrine—ABCB1—Metabolism—GCG—type 2 diabetes mellitus	1.26e-05	7.99e-05	CbGpPWpGaD
Amsacrine—ABCB1—Metabolism—SLC2A4—type 2 diabetes mellitus	1.26e-05	7.99e-05	CbGpPWpGaD
Amsacrine—CYP2D6—Metabolism—CYP2E1—type 2 diabetes mellitus	1.26e-05	7.95e-05	CbGpPWpGaD
Amsacrine—CYP2D6—Metabolism—SLC2A1—type 2 diabetes mellitus	1.24e-05	7.86e-05	CbGpPWpGaD
Amsacrine—CYP2D6—Metabolism—CYP1A2—type 2 diabetes mellitus	1.24e-05	7.86e-05	CbGpPWpGaD
Amsacrine—CYP2D6—Metabolism—CYP3A4—type 2 diabetes mellitus	1.21e-05	7.66e-05	CbGpPWpGaD
Amsacrine—CYP2D6—Metabolism—GCG—type 2 diabetes mellitus	1.19e-05	7.53e-05	CbGpPWpGaD
Amsacrine—CYP2D6—Metabolism—SLC2A4—type 2 diabetes mellitus	1.19e-05	7.53e-05	CbGpPWpGaD
Amsacrine—ABCB1—Metabolism—GNB3—type 2 diabetes mellitus	1.09e-05	6.89e-05	CbGpPWpGaD
Amsacrine—ABCB1—Metabolism—PPARGC1A—type 2 diabetes mellitus	1.09e-05	6.89e-05	CbGpPWpGaD
Amsacrine—ABCB1—Metabolism—HMOX1—type 2 diabetes mellitus	1.09e-05	6.86e-05	CbGpPWpGaD
Amsacrine—ABCB1—Metabolism—CAT—type 2 diabetes mellitus	1.07e-05	6.77e-05	CbGpPWpGaD
Amsacrine—ABCB1—Metabolism—APOB—type 2 diabetes mellitus	1.04e-05	6.57e-05	CbGpPWpGaD
Amsacrine—CYP2D6—Metabolism—PPARGC1A—type 2 diabetes mellitus	1.03e-05	6.49e-05	CbGpPWpGaD
Amsacrine—CYP2D6—Metabolism—GNB3—type 2 diabetes mellitus	1.03e-05	6.49e-05	CbGpPWpGaD
Amsacrine—CYP2D6—Metabolism—HMOX1—type 2 diabetes mellitus	1.02e-05	6.46e-05	CbGpPWpGaD
Amsacrine—ABCB1—Metabolism—GSTM1—type 2 diabetes mellitus	1.01e-05	6.39e-05	CbGpPWpGaD
Amsacrine—CYP2D6—Metabolism—CAT—type 2 diabetes mellitus	1.01e-05	6.38e-05	CbGpPWpGaD
Amsacrine—ABCB1—Metabolism—LPL—type 2 diabetes mellitus	9.92e-06	6.27e-05	CbGpPWpGaD
Amsacrine—CYP2D6—Metabolism—APOB—type 2 diabetes mellitus	9.79e-06	6.19e-05	CbGpPWpGaD
Amsacrine—ABCB1—Metabolism—ADCY5—type 2 diabetes mellitus	9.72e-06	6.14e-05	CbGpPWpGaD
Amsacrine—ABCB1—Metabolism—GPX1—type 2 diabetes mellitus	9.68e-06	6.12e-05	CbGpPWpGaD
Amsacrine—CYP2D6—Metabolism—GSTM1—type 2 diabetes mellitus	9.53e-06	6.02e-05	CbGpPWpGaD
Amsacrine—ABCB1—Metabolism—CD36—type 2 diabetes mellitus	9.43e-06	5.96e-05	CbGpPWpGaD
Amsacrine—CYP2D6—Metabolism—LPL—type 2 diabetes mellitus	9.35e-06	5.91e-05	CbGpPWpGaD
Amsacrine—ABCB1—Metabolism—PPP2CA—type 2 diabetes mellitus	9.31e-06	5.89e-05	CbGpPWpGaD
Amsacrine—CYP2D6—Metabolism—ADCY5—type 2 diabetes mellitus	9.16e-06	5.79e-05	CbGpPWpGaD
Amsacrine—CYP2D6—Metabolism—GPX1—type 2 diabetes mellitus	9.12e-06	5.77e-05	CbGpPWpGaD
Amsacrine—ABCB1—Metabolism—MTHFR—type 2 diabetes mellitus	8.94e-06	5.65e-05	CbGpPWpGaD
Amsacrine—CYP2D6—Metabolism—CD36—type 2 diabetes mellitus	8.89e-06	5.62e-05	CbGpPWpGaD
Amsacrine—CYP2D6—Metabolism—PPP2CA—type 2 diabetes mellitus	8.77e-06	5.55e-05	CbGpPWpGaD
Amsacrine—ABCB1—Metabolism—PPARA—type 2 diabetes mellitus	8.77e-06	5.54e-05	CbGpPWpGaD
Amsacrine—ABCB1—Metabolism—AGT—type 2 diabetes mellitus	8.49e-06	5.37e-05	CbGpPWpGaD
Amsacrine—CYP2D6—Metabolism—MTHFR—type 2 diabetes mellitus	8.42e-06	5.32e-05	CbGpPWpGaD
Amsacrine—ABCB1—Metabolism—CALM1—type 2 diabetes mellitus	8.35e-06	5.28e-05	CbGpPWpGaD
Amsacrine—ABCB1—Metabolism—APOE—type 2 diabetes mellitus	8.32e-06	5.26e-05	CbGpPWpGaD
Amsacrine—CYP2D6—Metabolism—PPARA—type 2 diabetes mellitus	8.26e-06	5.22e-05	CbGpPWpGaD
Amsacrine—ABCB1—Metabolism—APOA1—type 2 diabetes mellitus	8.22e-06	5.2e-05	CbGpPWpGaD
Amsacrine—CYP2D6—Metabolism—AGT—type 2 diabetes mellitus	8e-06	5.06e-05	CbGpPWpGaD
Amsacrine—CYP2D6—Metabolism—CALM1—type 2 diabetes mellitus	7.87e-06	4.97e-05	CbGpPWpGaD
Amsacrine—CYP2D6—Metabolism—APOE—type 2 diabetes mellitus	7.84e-06	4.96e-05	CbGpPWpGaD
Amsacrine—CYP2D6—Metabolism—APOA1—type 2 diabetes mellitus	7.75e-06	4.9e-05	CbGpPWpGaD
Amsacrine—ABCB1—Metabolism—PPARG—type 2 diabetes mellitus	7.25e-06	4.58e-05	CbGpPWpGaD
Amsacrine—ABCB1—Metabolism—INS—type 2 diabetes mellitus	7.11e-06	4.49e-05	CbGpPWpGaD
Amsacrine—CYP2D6—Metabolism—PPARG—type 2 diabetes mellitus	6.83e-06	4.32e-05	CbGpPWpGaD
Amsacrine—CYP2D6—Metabolism—INS—type 2 diabetes mellitus	6.7e-06	4.23e-05	CbGpPWpGaD
Amsacrine—ABCB1—Metabolism—ALB—type 2 diabetes mellitus	6.51e-06	4.12e-05	CbGpPWpGaD
Amsacrine—ABCB1—Metabolism—NOS3—type 2 diabetes mellitus	6.23e-06	3.94e-05	CbGpPWpGaD
Amsacrine—ABCB1—Metabolism—PIK3R1—type 2 diabetes mellitus	6.23e-06	3.94e-05	CbGpPWpGaD
Amsacrine—CYP2D6—Metabolism—ALB—type 2 diabetes mellitus	6.14e-06	3.88e-05	CbGpPWpGaD
Amsacrine—CYP2D6—Metabolism—NOS3—type 2 diabetes mellitus	5.87e-06	3.71e-05	CbGpPWpGaD
Amsacrine—CYP2D6—Metabolism—PIK3R1—type 2 diabetes mellitus	5.87e-06	3.71e-05	CbGpPWpGaD
Amsacrine—ABCB1—Metabolism—PTGS2—type 2 diabetes mellitus	5.7e-06	3.6e-05	CbGpPWpGaD
Amsacrine—CYP2D6—Metabolism—PTGS2—type 2 diabetes mellitus	5.37e-06	3.4e-05	CbGpPWpGaD
Amsacrine—ABCB1—Metabolism—AKT1—type 2 diabetes mellitus	2.86e-06	1.81e-05	CbGpPWpGaD
Amsacrine—CYP2D6—Metabolism—AKT1—type 2 diabetes mellitus	2.7e-06	1.71e-05	CbGpPWpGaD
